期刊文献+

重症肝炎患者凝血功能检测的临床价值 被引量:5

The Clinical Value of Detectioin of Coagulatioin Function in Patients with Severe Hepatitis
在线阅读 下载PDF
导出
摘要 目的探讨凝血四项在重症肝炎临床诊断治疗中的应用价值。方法对186例重症肝炎患者及60例正常体检者进行凝血四项检测结果对照分析。结果重症肝炎患者组与对照组相比凝血酶时间(TT)、活化部分凝血酶时间(aPTT)、凝血酶原时间(PT)均明显延长,纤维蛋白原(Fbg)的含量也显著减少,差异有统计学意义(P﹤0.01)。结论重症肝炎患者凝血四项检测能早期发现患者的凝血机制障碍,早期干预对预后有益。 Objective To discuss the clinical value of four indicators of coagulation factors of severe hepatitis. Methods Used automatic blood clots analyzer to test thrombin time( TT),activate part of thrombin time( aPTT),prothrombin time( PT) and fibrinogen( Fbg) content of 186 severe hepatitis patients and 60healthy cases. Results Thrombin time( TT),activate part thrombin time( aPTT),prothrombin time( PT) in severe liver disease patients compared with control group were significantly extended,fibrinogen( Fbg) content was also significantly reduced,there was a significant difference( P ﹤ 0. 01). Conclusion The early detection on coagulation factors of patients with severe hepatitis has very important clinical significance for the prevention and treatment of bleeding,rescue and treatment.
出处 《血栓与止血学》 2014年第4期185-186,共2页 Chinese Journal of Thrombosis and Hemostasis
关键词 重症肝炎 凝血功能 Severe hepatitis Coagulation function
  • 相关文献

参考文献5

二级参考文献17

  • 1王鸿利.血栓和血液检验[M].北京:北京科学出版社,1999.1321.
  • 2沈根荣 余书文.重症肝炎[M].天津:天津科学技术出版社,1998.53.
  • 3江忠仪 巫向前 王鸿利.乙型肝炎病毒纤溶活性标志物水平测定及其临床意义[J].实用医学检验杂志,1999,6(1):29-29.
  • 4[1]Teufelsbauer H, Proidl S, Havel M, et al. Early activation of hemostasis during cardiopulminary bypass: evidence for thrombin mediated hyperfibrinolysis. Thromb Haemost, 1992, 68(3): 250-252.
  • 5[2]Dayal S, Pati HP, Sharna MP, et al. Tissue plasminogen activator and plasminogen activator inhibitor status in Budd-Chiari syndrome.Haemostasis, 1996, 26 (5): 284-287.
  • 6[3]Huber K, Kirchheimer JC, Koringer C, et al. Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteersand in patients with different stages of liver cirrhosis. Throm Res,1991,62: 491-500.
  • 7[6]Ben AZ, Panagou M, Patch D, et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol, 1997, 26(3): 554-559.
  • 8[7]Sehetz MR. Coagulation disorders in acute renal failure. Kidney Int Suppl, 1998, 66: 96-101.
  • 9[8]Okajima K. Clinical revelevance of determination of plasma AT Ⅲ and α2 antiplasmin activities in patients with DIC application of the molecularmarkers for the analysis of pathophysiology of DIC. Rinsho Byori,1994, 42 (1): 45-55.
  • 10[9]Rocha E, Paramo JA, Montes R, et al. Acute generalized, widespread bleeding. Diagnosis and management. Haematologica, 1998, 83 ( 11 ):1024-1037.

共引文献547

同被引文献32

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部